The Extracorporeal CO2 Removal market is majorly driven by surging incidences of Chronic Obstructive Pulmonary Disease (COPD) and Acute Respiratory Distress Syndrome (ARDS), which has resulted in the introduction of novel products for stimulating blood flow and efficient gas exchange. Moreover, surging number of regulatory product approvals for different extracorporeal removal devices amid the pandemic further helped various product manufacturers to increase their product sales, thereby augmenting the market growth.
Category
Country
